Chromatin Regulator-Related Gene Signature for Predicting Prognosis and Immunotherapy Efficacy in Breast Cancer

Figure 2

Validation of the CR-related prognostic signature in BC patients. Risk score distribution for patients in low- and high-risk groups from the TCGA training set (a). Kaplan–Meier survival analysis of OS between the low-and high-risk groups from the TCGA training set (b). AUC in ROC analysis for risk scores predicting the OS from the TCGA training set (c). Risk score distribution for BC patients in low- and high-risk groups from the GEO validation set (d). Kaplan–Meier survival analysis of OS between the low- and high-risk groups from the GEO validation set (e). AUC in ROC analysis for risk scores predicting the OS from the GEO validation set (f).

(a)

(b)

(c)

(d)

(e)

(f)